Back
BridgeBio Pharma Stock Price Chart
Sponsored
BBIO
Sponsored
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.
Sell
50
BBIO
BridgeBio Pharma
Last Price:
27.46
Seasonality Move:
32.95%
7 Day Trial
ALL ACCESS PASS
$
7
7 Powerhouse Stocks to Buy and Hold Forever
Get it now.- The current trend is relatively stagnant and BBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
BridgeBio Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.69 | Buy |
20-day SMA: | 26.18 | Buy |
50-day SMA: | 28.77 | Sell |
200-day SMA: | 30.89 | Sell |
8-day EMA: | 26.15 | Buy |
20-day EMA: | 26.48 | Buy |
50-day EMA: | 28.53 | Sell |
200-day EMA: | 28.54 | Sell |
BridgeBio Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.79 | Sell |
Relative Strength Index (14 RSI): | 54.74 | Buy |
Chaikin Money Flow: | 955409 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.99 - 28.67) | Buy |
Bollinger Bands (100): | (27.86 - 37.9) | Sell |
BridgeBio Pharma Technical Analysis
Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BridgeBio Pharma Stock
Is BridgeBio Pharma Stock a Buy?
- BridgeBio Pharma share price is 27.74 while BBIO 8-day simple moving average is 25.69, which is a Buy signal.
- The stock price of BBIO is 27.74 while BridgeBio Pharma 20-day SMA is 26.18, which makes it a Buy.
- BridgeBio Pharma 50-day simple moving average is 28.77 while BBIO share price is 27.74, making it a Sell technically.
- BBIO stock price is 27.74 and BridgeBio Pharma 200-day simple moving average is 30.89, creating a Sell signal.
BBIO Technical Analysis vs Fundamental Analysis
Sell
50
BridgeBio Pharma (BBIO)
is a Sell
Is BridgeBio Pharma a Buy or a Sell?
-
BridgeBio Pharma stock is rated a Sell
The current BridgeBio Pharma [BBIO] share price is $27.74. The Score for BBIO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
BridgeBio Pharma Stock Info
Market Cap:
4.88B
Price in USD:
27.74
Share Volume:
1.2M
BridgeBio Pharma 52-Week Range
52-Week High:
44.32
52-Week Low:
12.75
Sell
50
BridgeBio Pharma (BBIO)
is a Sell
BridgeBio Pharma Share Price Forecast
-
What is the BridgeBio Pharma stock price today?
The BridgeBio Pharma stock price is 27.74 USD today. -
Will BBIO stock go up or go down?
BridgeBio Pharma> share price is forecast to RISE/FALL based on technical indicators -
Is BridgeBio Pharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, BridgeBio Pharma is overvalued.
Is BridgeBio Pharma Stock a Buy?
- BridgeBio Pharma share price is 27.74 while BBIO 8-day exponential moving average is 26.15, which is a Buy signal.
- The stock price of BBIO is 27.74 while BridgeBio Pharma 20-day EMA is 26.48, which makes it a Buy.
- BridgeBio Pharma 50-day exponential moving average is 28.53 while BBIO share price is 27.74, making it a Sell technically.
- BBIO stock price is 27.74 and BridgeBio Pharma 200-day simple moving average is 28.54, creating a Sell signal.
Fundamental Analysis of BridgeBio Pharma
Is BridgeBio Pharma a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.16 per share, an increase this year of $0.46 per share, and an increase next year of $0.54 per share.
Technical Analysis of BridgeBio Pharma
Should I short BridgeBio Pharma stock?
- BBIO Moving Average Covergence Divergence (MACD) indicator is -0.79, suggesting BridgeBio Pharma is a Sell
- BridgeBio Pharma Relative Strength Index (RSI) is 54.74, which suggest BridgeBio Pharma is overbought
- The Bollinger Bands (25) for BridgeBio Pharma is (24.99 - 28.67), which suggest BridgeBio Pharma is a Sell
- The Bollinger Bands (100) for BridgeBio Pharma is (27.86 - 37.9), which suggest BridgeBio Pharma is a Sell
* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.